June 24, 2025

The Power (and Profit) of Listening

Actively listening to your pre-surgery patients’ worries can lead to better premium conversion rates and pay dividends in the long term

The Ophthalmologist

June 24, 2025

Game-Based Therapy Matches Eye Patching Results

A randomized trial found that a gamified binocular therapy was as effective as patching in treating amblyopia in children, with faster early improvement and better adherence.

Conexiant

June 20, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

June 20, 2025

Retinal Changes Linked to Neurological Disease Progression

New research reviewed dozens of studies and revealed that visual dysfunction, including retinal changes, may serve as early signs of neurodegenerative and neurodevelopmental diseases, offering a noninvasive pathway for earlier diagnosis and disease monitoring.

Conexiant

June 18, 2025

Cataract phacoemulsification

Gavin W. Roddy, M.D., Ph.D., is a glaucoma surgeon and a cataract specialist at Mayo Clinic in Rochester, Minnesota. In this video, he performs a cataract phacoemulsification on an 80-year-old woman who has had an increasingly difficult time driving.

Mayo Clinic

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant

June 17, 2025

FDA Clears IND Amendment to Initiate Phase 2/3 Trial of Ocugen's OCU410ST for Stargardt Disease

The phase 2/3 clinical trial for OCU410ST, a modifier gene therapy candidate, will enroll 51 participants diagnosed with Stargardt disease. The primary objective of the trial is to evaluate the reduction in atrophic lesion size.

Ophthalmology Management

June 17, 2025

Aldeyra Therapeutics Resubmits Reproxalap NDA for the Treatment of DED

Per FDA agreement, the only new clinical data included in the resubmitted new drug application were from the recently completed dry eye chamber trial, which achieved the primary endpoint, according to the company.

Ophthalmology Management

June 16, 2025

AI in Eye Care: Past, Present, and Future

The history, current applications, and potential future impact of AI on patients and eye care professionals

The Ophthalmologist